Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases

Experimental Biology and Medicine

Volumn 234, Issue 10, 2009, Pages 1244-1252

  Latimer, Paul ^a   Menchaca, Marla ^b   Snyder, Rachel M ^b   Yu, Weiping ^b   Gilbert, Brian E ^c   Sanders, Bob G ^b   Kline, Kimberly ^a  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Paclitaxel; Vitamin E analog

Indexed keywords

2,5,7,8 TETRAMETHYL (12 TRIMETHYLTRIDECYL) CHROMAN 6 YLOXYACETIC ACID; ALPHA TOCOPHEROL DERIVATIVE; CD31 ANTIGEN; KI 67 ANTIGEN; LIPOSOME; PACLITAXEL; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; BREAST CANCER; CANCER MODEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; LIPOSOMAL DELIVERY; LIVER TOXICITY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NEPHROTOXICITY; NICK END LABELING; NONHUMAN; PRIMARY TUMOR; TREATMENT DURATION; TUMOR CELL; TUMOR VOLUME;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; LIPOSOMES; LYMPH NODES; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; TUMOR BURDEN; VITAMIN E;

ANIMALIA; MURINAE;

EID: 70349679107     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0901-RM-8     Document Type: Article

References (26)

1. Whelan J. Targeted taxane therapy for cancer. Drug Discovery Today 7:90-92, 2002.
2. Horwitz SB. Taxol (paclitaxel): mechanisms of action. Ann Oncol 5(Suppl 6):S3-S6, 1994.
3. Sharma A, Mayhew E, Bolcsak L, Cavanaugh C, Harmon P, Janoff A, Bernacki RJ. Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer 71:103-107, 1997. (Pubitemid 27158416)
4. Cabanes A, Briggs KE, Gokhale PC, Treat JA, Rahman A. Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel. Int J Oncol 12:1035-1040, 1998. (Pubitemid 28186763)
5. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, Gilbert BE, Conti C, Sanders BG, Kline K. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther 2:437-444, 2003.
6. Hahn T, Szabo L, Gold M, Ramanathapuram L, Hurley LH, Akporiaye ET. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Res 66:9374-9378, 2006. (Pubitemid 44623632)
7. Anderson K, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K. Alpha-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis. Exp Biol Med 229:1169-1176, 2004. (Pubitemid 39602260)
8. Jia L, Yu W, Wang P, Sanders BG, Kline K. In vivo and in vitro studies of anticancer actions of α-TEA for human prostate cancer cells. Prostate 68:849-860, 2007.
9. Kline K, Lawson KA, Yu W, Sanders BG. Vitamin E and cancer. Vitam Horm 76:435-461, 2007.
10. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Sanders BG, Kline K. Comparison of vitamin E derivatives α-TEA and VES in reduction of mouse mammary tumor burden and metastasis. Exp Biol Med 229:954-963, 2004. (Pubitemid 39539382)
11. Clarke R. Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer Res Treat 46:255-278, 1997. (Pubitemid 28029528)
12. Koshkina NV, Waldrep JC, Roberts LE, Golunski E, Melton S, Knight V. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res 7:3258-3262, 2001. (Pubitemid 32963851)
13. 2-enriched air: pharmacokinetic studies. Cancer Chemother Pharmacol 47:451-456, 2001.
14. Knight V, Koshkina NV, Waldrep JC, Giovanella BC, Gilbert BE. Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice. Cancer Chemother Pharmacol 44:187-192, 1999. (Pubitemid 29350172)
15. Zhang S, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG, Kline K. Vitamin E analog alpha-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice. Breast Cancer Res Treat 87:111-121, 2004. (Pubitemid 39237789)
16. Ocana A, Pandiella A. Identifying breast cancer drugable oncogenic alterations: lessons learned and future targeted options. Clin Cancer Res 14:961-970, 2008. (Pubitemid 351302540)
17. Volk LD, Flister MJ, Bivens CM, Stutzman A, Desai N, Trieu V, Ran S. Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy. Neoplasia 10:613-623, 2008. (Pubitemid 351770305)
18. Bullock K, Blackwell K. Clinical efficacy of taxane-trastuzumab combination regimens for HER-2-positive metastatic breast cancer. Oncologist 13:515-525, 2008. (Pubitemid 351872869)
19. Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon-Shiong P. Increased anti-tumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 12:1317-1324, 2006. (Pubitemid 43342524)
20. Perry MC. The Chemotherapy Source Book (4th edition). Philadelphia, PA: Lippincott, Williams & Wilkins, pp371, 2008.
21. Wu Y, Zu K, Ni J, Yeh S, Kasi D, James NS, Chemler S, Ip C. Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention. Anticancer Res 24:395-1302, 2004. (Pubitemid 40468668)
22. Neuzil J, Tomasetti M, Mellick AS, Alleva R, Salvatore BA, Birringer M, Fariss MW. Vitamin E analogues: a new class of inducers of apoptosis with selective anti-cancer effects. Curr Cancer Drug Targets 4:355-372, 2004. (Pubitemid 38797247)
23. Constantinou C, Papas A, Constantinou AI. Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer 123:739-752, 2008. (Pubitemid 352032398)
24. Doppalapudi RS, Riccio ES, Rausch LL, Shimon JA, Lee PS, Mortelmans KE, Kapetanovic IM, Crowell JA, Mirsalis JC. Evaluation of chemopreventive agents for genotoxic activity. Mutation Res 629:148-160, 2007.
25. Latimer P. Investigation of the effects of α-TEA, 9-nitrocamptothecin and paclitaxel alone and in combination on 66cl-4-GFP murine mammary cancer cells in vitro and in vivo. PhD dissertation. University of Texas at Austin, December 2007.
26. Lawson KA, Anderson K, Snyder RM, Simmons-Menchaca M, Atkinson J, Sun LZ, Bandyopadhyay A, Knight V, Gilbert BE, Sanders BG, Kline K. Novel vitamin E analogue and 9-nitrocamptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis. Cancer Chemother Pharmacol 54:421-431, 2004. (Pubitemid 39462967)